doi: 10.1007/s12020-019-02055-z
The pen versions of GLP-1s are delivered via subcutaneous injections meaning they are injected into the fatty tissue layer just below the skin, typically in the abdomen, thigh, or upper arm
GLP-1 Pipeline Update: November 2025 Quarterly view of the GLP-1 pipeline and anticipated indications Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Associate Vice President, Clinical Information Carole Kerzic, RPh Executive Editor Drug Information Pharmacist Principal Nicole Kjesbo, PharmD, BCPS Executive Editor Clinical Program Development Director Senior, Pipeline DISCLAIMER The drug pipeline is fluid
And unlike those approaches, GLP-1 therapy under medical supervision has a clinical success rate backed by two decades of research
Are protein bars and shakes a good idea